Stockreport

Keros Therapeutics Announces Preliminary Results of Tender Offer

Keros Therapeutics, Inc. - common stock  (KROS) 
PDF LEXINGTON, Mass., Nov. 19, 2025 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros” or the “Company”) (Nasdaq: KROS), today announced the preliminary results of its [Read more]